Biopharmaceutical Manufacturing

Predefined Single-Use Production Platforms for Biomanufacturing

The biopharmaceutical industry can reduce the time and cost required to bring products to the clinic and the market by taking advantage of single-use production platforms. These platforms integrate proven services and technologies for the development and manufacture of mAbs, vaccines, and bioconjugates.

Companies can streamline early-stage process development activities by leveraging the expertise and experience Sartorius has acquired over many years while establishing biomanufacturing processes for clients. Furthermore, Sartorius can expedite the engineering of single-use and hybrid processes for scale-up during late-stage activities using process templates that reduce design costs and increase standardization.

Racing for a Viable Vaccine: Expediting Vaccine Development Amidst a Pandemic
Fight the Coronavirus

Sartorius Biomanufacturing Platforms

Vaccines

Learn More

Blood and Plasma

Discover our Technologies for Plasma Fractionation and Recombinant Blood Factors

Learn More

Bioconjugation

Learn More

Regenerative Medicine

Learn More

Biosimilars

Learn More

Intensified Processing

Learn More
Publication: A Look into the Future of Bioprocessing
Download Now

Publications

Introducing New Bioprocessing Technologies in the Era of COVID-19

Read Article

Bioprocessing 4.0 - Where Are We With Smart Manufacturing in 2020?

Read Article

Webinar on Sartorius End-to-End, Single-Use Downstream Solution

Learn how Sartorius' new, single-use technologies meet the growing demands of clinical and commercial biopharmaceutical environments.

Watch On-Demand Webinar Now

Explore Sartorius

Bioprocess Development Engineering

Learn More

Expert Voice, Publications and Case Studies

Learn More

Sartorius Application Center

Learn More